Tag: Outlook
India Biotech Outlook 2025: The India Advantage at BIO Boston 2025
BioVoice News and the International Contract Pharma Association (ICPA) have collaborated to present an exclusive publication that will highlight India’s leadership in biotech and provide a powerful platform for companies to maximize their presence
Credit profile of Indian pharma companies to remain healthy in FY2025:...
Revenue growth to moderate to 8-10% in FY2025, post a healthy 13-14% YoY expansion in FY2024
Outlook for the Indian pharma industry remains stable: ICRA
Continued pricing pressures in the US and European markets and cost inflation likely to result in 120-150 bps contraction in operating profit margin for ICRA sample set in FY2023
Outlook 2022: Pharma experts predict a stable future for the industry
The last two years steered the pharma industry towards innovative breakthroughs across the patient journey that helped the world recover from the pandemic
“We are excited about the DNA Bill as a game changer”
Mentioned Dr Rajnish Bharti, General Manager, Promega Biotech in an exclusive face to face interaction with the BioVoice where he also talked about current activities and future outlook...……......